All DiaSorin Infectious Diseases products are registered in compliance with the European CE mark rules with many assay also having FDA approval.
- Hepatitis and
Infectious Diseases (ID) represent one of the major causes of death in the world. The growth of ID incidence has lead to a continuous need for novel diagnostic tests to new agents and improvement in performances of those already on the market. In addition, the increased number of diagnostic tests to be performed every day in a routine lab has elicited the demand of tests that are easy to perform and quick in providing results for faster diagnosis and therapy. Infectious disease serology means determination of antibodies to different pathogens with the following aims: to assess the presence of ongoing infection or to follow progression of the disease to assess the immune status.
In 1970 DiaSorin began the development of Infectious Diseases products designed for use with ELISA technology. Since 2001 it has launched a broad array of new CLIA products, with unique assays for diagnosis of Infectious Diseases on LIAISON® systems.